Ninepoint Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$509K	Buy	878 +355	+68%	+$201K	0.06%	114
2025 Q3	$254K	Buy	+523	New	+$243K	0.04%	108
2024 Q4	–	Sell	-1,154	Closed	-$714K	–	100
2024 Q3	$714K	Sell	1,154 -45	-4%	-$26.6K	0.09%	76
2024 Q2	$663K	Sell	1,199 -128	-10%	-$73.3K	0.07%	76
2024 Q1	$771K	Hold	1,327	–	–	0.1%	63
2023 Q4	$704K	Buy	1,327 +117	+10%	+$56.6K	0.1%	55
2023 Q3	$612K	Hold	1,210	–	–	0.07%	58
2023 Q2	$631K	Buy	1,210 +143	+13%	+$77.2K	0.08%	59
2023 Q1	$615K	Buy	1,067 +278	+35%	+$157K	0.08%	51
2022 Q4	$434K	Buy	+789	New	+$418K	0.06%	55
2022 Q1	–	Sell	-802	Closed	-$535K	–	102
2021 Q4	$535K	Buy	+802	New	+$501K	0.2%	40
2021 Q2	–	Sell	-1,020	Closed	-$466K	–	97
2021 Q1	$466K	Buy	1,020 +229	+29%	+$109K	0.33%	43
2020 Q4	$368K	Sell	791 -282	-26%	-$132K	0.22%	55
2020 Q3	$474K	Hold	1,073	–	–	0.45%	17
2020 Q2	$389K	Sell	1,073 -230	-18%	-$77.1K	0.47%	33
2020 Q1	$370K	Sell	1,303 -306	-19%	-$96.5K	0.56%	27
2019 Q4	$523K	Hold	1,609	–	–	0.41%	35
2019 Q3	$469K	Sell	1,609 -556	-26%	-$159K	0.38%	58
2019 Q2	$636K	Sell	2,165 -1,640	-43%	-$452K	0.36%	51
2019 Q1	$1.04M	Hold	3,805	–	–	0.43%	45
2018 Q4	$852K	Sell	3,805 -295	-7%	-$69.2K	0.52%	33
2018 Q3	$1M	Hold	4,100	–	–	0.3%	47
2018 Q2	$849K	Buy	4,100 +1,400	+52%	+$297K	0.24%	51
2018 Q1	$557K	Buy	2,700 +1,200	+80%	+$252K	0.13%	68
2017 Q4	$285K	Buy	+1,500	New	+$287K	0.05%	111